Main > ONCOLOGY (**) > Multiple Myeloma R/R *** > Treatment > USA. J. Bispecific T-Cell Engager>B

---

USA. J. Bispecific T-Cell Engager>B's subsections
(*) USA Approval Date: 2022. 10.25
>4 prior lines of therapy>
>Ab Binding to CD3 receptor & BCMA
Company
Generic Name
TM
TM Web-Site
USA Patent Number

USA. J. Bispecific T-Cell Engager>B's products
This section has no products